HOME >> BIOLOGY >> NEWS
Photosystem I -- An Intermediate Step -- May Not Be Necessary For Plants

ITHACA, N.Y. -- Plant biologists have long held the view that photosynthesis -- the process by which cells in green plants convert the energy of sunlight into chemical energy and use carbon dioxide to produce sugars -- needs two intermediate light-dependent reactions for successful energy conversion: Photosystem II and Photosystem I.

But according to a new study reported today (July 19), that dogma may have gone for a walk, and scientists may have to rethink some aspects of how photosynthesis works. "Scientists have thought they understood photosynthesis for a long time, and this revelation flies in the face of what we know," said Thomas G. Owens, Cornell University associate professor of plant biology. "What does this all mean? No one knows yet."

The Z scheme is the classic example of how scientists describe the light-dependent reactions of photosynthesis. When photons -- particles of light -- enter a plant cell, their energy is used to power two sequential light-dependent reactions. In Photosystem II (PSII), the light energy is used to split water, producing oxygen and electrons. In Photosystem I (PSI), these electrons are used to produce compounds that ultimately react with carbon dioxide to produce carbohydrates, lipids, proteins and nucleic acids -- the fundamental components of life.

But Owens and researchers from the Oak Ridge National Laboratory in Tennessee found that in some cases photosynthesis can occur in the absence of PSI, they report in the journal Science (July 19, 1996). The report, "Oxygenic Photoautotrophic Growth Without Photosystem I," was authored by James W. Lee, C.V. Tevault and Elias Greenbaum, all of the Oak Ridge National Laboratory, and Cornell's Owens.

The scientists from Oak Ridge used artificially developed mutants of a green alga to find this new life process.

"It is a very important discovery; I didn't believe any of this stuff when it was first reported. I thought it was impossible, but cooperation between
'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
19-Jul-1996


Page: 1 2

Related biology news :

1. Oxygen-Carrying Myoglobin Not Necessary For Survival
2. Plants will not save us from greenhouse gases
3. Plants for the future: A European vision for plant biotechnology towards 2025
4. Plants circadian clocks tune into latitude to enhance fitness
5. Plants and people share a molecular signaling system, researchers discover
6. Nonnative Invasive Plants of Southern Forests
7. Plants, insects play cat and mouse game
8. Plants vs. disease: Trench warfare at the molecular level
9. Plants as plants: gene could convert crops to plastics factories
10. Plants, pathogens engage in trench warfare
11. Study: Microgravity May Enhance Gene Transfer In Plants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Photosystem Intermediate Step May Not Necessary For Plants

(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: